...
首页> 外文期刊>Organic letters >Reengineering an azaphilone biosynthesis pathway in Aspergillus nidulans to create lipoxygenase inhibitors
【24h】

Reengineering an azaphilone biosynthesis pathway in Aspergillus nidulans to create lipoxygenase inhibitors

机译:重构构巢曲霉中的azaphilone生物合成途径以创建脂氧合酶抑制剂

获取原文
获取原文并翻译 | 示例

摘要

Sclerotiorin, an azaphilone polyketide, is a bioactive natural product known to inhibit 15-lipoxygenase and many other biological targets. To readily access sclerotiorin and analogs, we developed a 2-3 step semisynthetic route to produce a variety of azaphilones starting from an advanced, putative azaphilone intermediate (5) overproduced by an engineered strain of Aspergillus nidulans. The inhibitory activities of the semisynthetic azaphilones against 15-lipoxygenase were evaluated with several compounds displaying low micromolar potency.
机译:巩膜硬化蛋白,一种氮杂苯甲酰胺聚酮化合物,是一种具有生物活性的天然产物,已知能够抑制15-脂氧合酶和许多其他生物靶标。为了方便地获取巩膜铁蛋白及其类似物,我们开发了2-3步的半合成路线,以生产先进的推定的氮杂苯甲酮中间体(5)来生产各种氮杂苯乙酮,而中间体是由工程化的构巢曲霉(Aspergillus nidulans)过量生产的。用几种显示低微摩尔效价的化合物评估了半合成氮杂苯酮对15-脂氧合酶的抑制活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号